Raras
Buscar doenças, sintomas, genes...
Degeneração vítreo-retiniana em floco de neve
ORPHA:91496CID-10 · H35.5CID-11 · 9B70OMIM 193230DOENÇA RARA

A Degeneração Vítreo-Retiniana em Floco de Neve (SVD) é uma doença dos olhos que se caracteriza pelo aparecimento de pequenas formações parecidas com grânulos ou flocos de neve na retina. Além disso, causa uma degeneração das fibras do vítreo (o gel transparente que preenche o olho) e catarata. Não se sabe quantas pessoas têm essa doença, mas ela já foi identificada em várias famílias. É uma condição hereditária, transmitida de forma autossômica dominante, o que significa que basta receber uma cópia do gene alterado de um dos pais para desenvolvê-la. O gene responsável por essa doença foi encontrado em uma pequena área do cromossomo 2q36.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A Degeneração Vítreo-Retiniana em Floco de Neve (SVD) é uma doença dos olhos que se caracteriza pelo aparecimento de pequenas formações parecidas com grânulos ou flocos de neve na retina. Além disso, causa uma degeneração das fibras do vítreo (o gel transparente que preenche o olho) e catarata. Não se sabe quantas pessoas têm essa doença, mas ela já foi identificada em várias famílias. É uma condição hereditária, transmitida de forma autossômica dominante, o que significa que basta receber uma cópia do gene alterado de um dos pais para desenvolvê-la. O gene responsável por essa doença foi encontrado em uma pequena área do cromossomo 2q36.

Publicações científicas
18 artigos
Último publicado: 2023 Mar 1

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
50
pacientes catalogados
Início
Adult
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: H35.5
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Características mais comuns

83%prev.
Catarata
Frequência: 5/6
80%prev.
Córnea guttata
Frequência: 4/5
67%prev.
Degeneração vítreo-retiniana em floco de neve
Frequência: 4/6
21%prev.
Descolamento de retina
Frequência: 3/14
17%prev.
Vítreo opticamente vazio
Ocasional (29-5%)
Herança autossômica dominante
7sintomas
Muito frequente (2)
Frequente (1)
Ocasional (2)
Sem dados (2)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 7 características clínicas mais associadas, ordenadas por frequência.

CatarataCataract
Frequência: 5/683%
Córnea guttataCorneal guttata
Frequência: 4/580%
Degeneração vítreo-retiniana em floco de neveSnowflake vitreoretinal degeneration
Frequência: 4/667%
Descolamento de retinaRetinal detachment
Frequência: 3/1421%
Vítreo opticamente vazioOptically empty vitreous
Ocasional (29-5%)17%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa3desde 2023
Total histórico18PubMed
Últimos 10 anos10publicações
Pico20192 papers
Linha do tempo
2023Hoje · 2026
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal dominant.

KCNJ13Inward rectifier potassium channel 13Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. KCNJ13 has a very low single channel conductance, low sensitivity to

LOCALIZAÇÃO

MembraneCell membrane

MECANISMO DE DOENÇA

Snowflake vitreoretinal degeneration

Developmental and progressive hereditary eye disorder that affects multiple tissues within the eye. Diagnostic features of SVD include fibrillar degeneration of the vitreous humor, early-onset cataract, minute crystalline deposits in the neurosensory retina, and retinal detachment.

EXPRESSÃO TECIDUAL(Tecido-específico)
Intestino delgado
21.4 TPM
Rim - Medula
1.3 TPM
Skin Not Sun Exposed Suprapubic
1.1 TPM
Tireoide
0.9 TPM
Skin Sun Exposed Lower leg
0.8 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (3)
Leber congenital amaurosis 16snowflake vitreoretinal degenerationLeber congenital amaurosis
HGNC:6259UniProt:O60928

Variantes genéticas (ClinVar)

45 variantes patogênicas registradas no ClinVar.

🧬 KCNJ13: GRCh37/hg19 2q33.3-37.3(chr2:206965837-242783384)x3 ()
🧬 KCNJ13: GRCh37/hg19 2q35-37.3(chr2:216815496-242782258)x3 ()
🧬 KCNJ13: GRCh37/hg19 2q36.2-37.3(chr2:225995545-237594511)x3 ()
🧬 KCNJ13: GRCh37/hg19 2q35-37.3(chr2:218376403-242783384)x3 ()
🧬 KCNJ13: Single allele ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 7 variantes classificadas pelo ClinVar.

2
5
Patogênica (28.6%)
VUS (71.4%)
VARIANTES MAIS SIGNIFICATIVAS
GIGYF2: NM_002242.4(KCNJ13):c.913C>T (p.Arg305Ter) [Conflicting classifications of pathogenicity]
GIGYF2: NM_002242.4(KCNJ13):c.484C>T (p.Arg162Trp) [Pathogenic/Likely pathogenic]
GIGYF2: NM_002242.4(KCNJ13):c.155G>A (p.Arg52His) [Uncertain significance]
GIGYF2: NM_002242.4(KCNJ13):c.143T>C (p.Leu48Pro) [Uncertain significance]
GIGYF2: NM_002242.4(KCNJ13):c.584G>A (p.Arg195Gln) [Uncertain significance]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Degeneração vítreo-retiniana em floco de neve

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
9 papers (10 anos)
#1

The unique structural characteristics of the Kir 7.1 inward rectifier potassium channel: a novel player in energy homeostasis control.

American journal of physiology. Cell physiology2023 Mar 01

The inward rectifier potassium channel Kir7.1, encoded by the KCNJ13 gene, is a tetramer composed of two-transmembrane domain-spanning monomers, closer in homology to Kir channels associated with potassium transport such as Kir1.1, 1.2, and 1.3. Compared with other channels, Kir7.1 exhibits small unitary conductance and low dependence on external potassium. Kir7.1 channels also show a phosphatidylinositol 4,5-bisphosphate (PIP2) dependence for opening. Accordingly, retinopathy-associated Kir7.1 mutations mapped at the binding site for PIP2 resulted in channel gating defects leading to channelopathies such as snowflake vitreoretinal degeneration and Leber congenital amaurosis in blind patients. Lately, this channel's role in energy homeostasis was reported due to the direct interaction with the melanocortin type 4 receptor (MC4R) in the hypothalamus. As this channel seems to play a multipronged role in potassium homeostasis and neuronal excitability, we will discuss what is predicted from a structural viewpoint and its possible implications for hunger control.

#2

Phenotypic expansion of KCNJ13-associated snowflake vitreoretinal degeneration.

Ophthalmic genetics2023 Oct

An 18-year old highly myopic woman presented with bilateral retinoschisis associated with a unilateral macular hole in the right eye and vitreomacular traction in the left eye. Genetic studies disclosed a heterozygous pathogenic variant in the KCNJ13 gene was identified (c.484C>T (p.Arg162Trp)), consistent with a diagnosis of snowflake vitreoretinal degeneration (SVD). While there were no corneal guttata, juvenile cataracts, or perivascular sheathing in this case, salient features of SVD included a fibrillar vitreous structure, crystalline retinopathy, and flattened optic nerves. The patient developed a FTMH in the left eye at 17 months follow up, followed by a rhegmatogenous retinal detachment (RRD) requiring 2 surgical repairs. This case expands on the spectrum of clinical features in SVD, including retinoschisis and FTMH. It also characterizes optical coherence tomography findings in this rare disease entity. We emphasize the importance of using panel-based genetic testing to clinically distinguish and further define atypical vitreoretinopathies.

#3

A novel phenotype associated with the R162W variant in the KCNJ13 gene.

Ophthalmic genetics2022 Aug

Pathogenic variants in KCNJ13 have been associated with both autosomal dominant Snowflake vitreoretinal degeneration (SVD) and autosomal recessive Leber congenital amaurosis. SVD is characterized by aberrant vitreoretinal interface leading to increased risk of retinal detachment, crystalline retinal snowflake deposits, optic disc abnormalities, early-onset cataract, and cornea guttae. Reduced dark adaptation and reduced scotopic rod b-waves have also been described. We report a novel phenotype associated with the R162W variant in KCNJ13. Four affected members of a Swedish family were included. Three of them were examined with best corrected visual acuity, Goldmann perimetry, full-field-and multifocal electroretinography, optical coherence tomography, fundus color photographs, fundus autofluorescence images, slit lamp inspection, and genetic testing. The fourth subject only managed genetic testing. All subjects carry the pathogenic missense variant; c.484C>T (NM_002242.4), R162W, in KCNJ13. ERG measurements revealed reduced macular-as well as general retinal function. Two of the subjects had a history of retinal detachment and the two younger subjects demonstrated early onset cataract. They all had structural macular changes and slightly gliotic optic discs. In this family, the R162W variant in KCNJ13, previously described in association with SVD, causes a somewhat novel phenotype including macular dystrophy and moderate reduction of general retinal function as the main features combined with disc abnormalities, retinal detachment, and presenile cataract that has been described before. In times of up-coming gene-based therapies, it is important to report new genotype-phenotype associations to improve the possibilities to identify future treatment candidates.

#4

Retinal Development and Pathophysiology in Kcnj13 Knockout Mice.

Frontiers in cell and developmental biology2021

Purpose: We constructed and characterized knockout and conditional knockout mice for KCNJ13, encoding the inwardly rectifying K+ channel of the Kir superfamily Kir7.1, mutations in which cause both Snowflake Vitreoretinal Degeneration (SVD) and Retinitis pigmentosa (RP) to further elucidate the pathology of this disease and to develop a potential model system for gene therapy trials. Methods: A Kcnj13 knockout mouse line was constructed by inserting a gene trap cassette expressing beta-galactosidase flanked by FRT sites in intron 1 with LoxP sites flanking exon two and converted to a conditional knockout by FLP recombination followed by crossing with C57BL/6J mice having Cre driven by the VMD2 promoter. Lentiviral replacement of Kcnj13 was driven by the EF1a or VMD2 promoters. Results: Blue-Gal expression is evident in E12.5 brain ventricular choroid plexus, lens, neural retina layer, and anterior RPE. In the adult eye expression is seen in the ciliary body, RPE and choroid. Adult conditional Kcnj13 ko mice show loss of photoreceptors in the outer nuclear layer, inner nuclear layer thinning with loss of bipolar cells, and thinning and disruption of the outer plexiform layer, correlating with Cre expression in the overlying RPE which, although preserved, shows morphological disruption. Fundoscopy and OCT show signs of retinal degeneration consistent with the histology, and photopic and scotopic ERGs are decreased in amplitude or extinguished. Lentiviral based replacement of Kcnj13 resulted in increased ERG c- but not a- or b- wave amplitudes. Conclusion: Ocular KCNJ13 expression starts in the choroid, lens, ciliary body, and anterior retina, while later expression centers on the RPE with no/lower expression in the neuroretina. Although KCNJ13 expression is not required for survival of the RPE, it is necessary for RPE maintenance of the photoreceptors, and loss of the photoreceptor, outer plexiform, and outer nuclear layers occur in adult KCNJ13 cKO mice, concomitant with decreased amplitude and eventual extinguishing of the ERG and signs of retinitis pigmentosa on fundoscopy and OCT. Kcnj13 replacement resulting in recovery of the ERG c- but not a- and b-waves is consistent with the degree of photoreceptor degeneration seen on histology.

#5

Altered phosphatidylinositol regulation of mutant inwardly rectifying K+ Kir7.1 channels associated with inherited retinal degeneration disease.

The Journal of physiology2021 Jan

Kir7.1 K+ channel expressed in retinal pigment epithelium is mutated in inherited retinal degeneration diseases. We study Kir7.1 in heterologous expression to test the hypothesis that pathological R162 mutation to neutral amino acids results in loss of a crucial site that binds PI(4,5)P2 . Although R162W mutation inactivates Kir7.1, changes to smaller volume (e.g. Gln) amino acids are tolerated or even enhance function (Ala or Cys). Chemical modification of Kir7.1-R162C confirms that large residues of the size of Trp are incompatible with normal channel function even if positively charged. In addition to R162, K164 (and possibly K159) forms a binding site for the phosphoinositide and is essential for channel activity. R162 substitution with a large, neutral side chain like Trp exerts a dominant negative effect on Kir7.1 activity such that less than one fifth of the full activity is expected in a cell expressing the same amount of mutant and wild-type channels. Mutations in the Kir7.1 K+ channel, highly expressed in retinal pigment epithelium, have been linked to inherited retinal degeneration diseases. Examples are mutations changing Arg 162 to Trp in snowflake vitreoretinal degeneration (SVD) and Gln in retinitis pigmentosa. R162 is believed to be part of a site that binds PI(4,5)P2 and stabilises the open state. We have tested the hypothesis that R162 mutation to neutral amino acids will result in the loss of this crucial interaction to the detriment of channel function. Our findings indicate that although R612W mutation inactivates Kir7.1, changes to smaller volume (e.g. Gln) amino acids are tolerated or even enhance function (Ala or Cys). Cys chemical modification of Kir7.1-R162C confirms that large residues of the size of Trp are incompatible with normal channel function even if positively charged. Experiments titrating the levels of plasma membrane PI(4,5)P2 with voltage-dependent phosphatase DrVSP reveal that, in addition to R162, K164 (and possibly K159) forms a binding site for the phosphoinositide and ensures channel activity. Finally, the use of a concatemeric approach shows that substitution of R162 with a large, neutral side chain mimicking a Trp residue exerts a dominant negative effect on Kir7.1 activity such that less than one fifth of the full activity is expected in heterozygous cells carrying the SVD mutation. Our results suggest that if mutations in the human KCNJ13 gene resulting in the neutralisation of R162 and Kir7.1 malfunction led to retinal degeneration diseases, their severity might depend on the nature of the side chain of the replacing amino acid.

Publicações recentes

Ver todas no PubMed

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Degeneração vítreo-retiniana em floco de neve.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Degeneração vítreo-retiniana em floco de neve

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. The unique structural characteristics of the Kir 7.1 inward rectifier potassium channel: a novel player in energy homeostasis control.
    American journal of physiology. Cell physiology· 2023· PMID 36717105mais citado
  2. Phenotypic expansion of KCNJ13-associated snowflake vitreoretinal degeneration.
    Ophthalmic genetics· 2023· PMID 36440807mais citado
  3. A novel phenotype associated with the R162W variant in the KCNJ13 gene.
    Ophthalmic genetics· 2022· PMID 35477418mais citado
  4. Retinal Development and Pathophysiology in Kcnj13 Knockout Mice.
    Frontiers in cell and developmental biology· 2021· PMID 35096838mais citado
  5. Altered phosphatidylinositol regulation of mutant inwardly rectifying K+ Kir7.1 channels associated with inherited retinal degeneration disease.
    The Journal of physiology· 2021· PMID 33219695mais citado

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:91496(Orphanet)
  2. OMIM OMIM:193230(OMIM)
  3. MONDO:0008663(MONDO)
  4. GARD:9706(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q55345684(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Degeneração vítreo-retiniana em floco de neve

ORPHA:91496 · MONDO:0008663
Prevalência
<1 / 1 000 000
Casos
50 casos conhecidos
Herança
Autosomal dominant
CID-10
H35.5 · Distrofias hereditárias da retina
CID-11
Início
Adult
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C1860405
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades